Together with our reputable Indian and international collaborators, Hexaphoenix Pharma offers you a broad portfolio of Prescription medicines, OTC and General Pharmacy products in various indications and in different development stages up to finished products – ready for market.

International Market/Global Presence:

We believe in partnerships. We are not looking for “clients” or “customers” but for partners. We believe in long-term relationships that bring value to both businesses.

Hexaphoenix Pharmaceutical product enriches superior recognition, largely due to consistent customer satisfaction. We maintain world-class quality for our products and services across domestic and overseas markets, thus ensuring that every patient has access to the best medicines in the world.

The company plans to expand its footprint in the same therapy with molecules approved from EUGMP and UKMHRA authorities to represent it in all the dosage forms in semi regulated markets such as Latin America, Africa, CIS and South East Asia.

Always welcome partner companies who provide their approved molecules from Regulated Authorities as In-Licensing to make it available for other markets where patent are expiry to collaboration with us.

REGULATORY EXPERTISE:

Our Service for Finished Pharmaceutical Product contains:

  • Product development and regulatory strategies
  • Communication with regulatory authorities
  • Preparation of country specific submission documents / medical writing
  • Dossier evaluation and gap analyses
  • Writing chemical-pharmaceutical documentation (CMC, Module 3)
  • Writing and review of clinical (CO) and non-clinical overviews (NCO)
  • Compiling pharmacological-toxicological and clinical documentation
  • Writing quality overall summaries (pharmaceutical-chemical expert reports)
  • ACTD/CTD/eCTD in-house publishing
  • BA/BE studies
  • Pre-submission and/ or scientific advice procedures at regulatory authorities
  • Filling of variations throughout the medicine lifecycle;
  • Preparation of product information (PI) – Product specification, patient information leaflet, Label Composition
  • Translations for other countries Language Portuguese, French, Spanish and European Countries as well.

Strength: 100mg /200mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 75mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg /500mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/20mg/30mg/40mg/60mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30mg/60mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 40/160mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 500mg/750mg/1000mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: Prochlorperazine |  Tablet |  5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 7.5mg/5ml, 30mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5/10/20/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 375mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 800mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg / 7.5mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 50/100mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 12.5/25/50/100mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 0.5mg / 0.75mg / 1.0mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg

Dosage: ODT (Lingual) Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 8mg /16mg / 24mg /48mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 0.5mg / ml

Dosage: Oral Solution

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 500 mg / 1000mg

Dosage: Granules in Sachet

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 1mg/5mg/10mg

Dosage: Film Coated Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 62.5 mcg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 5 IU and 10 IU

Dosage: Injection

Approved Authority: WHO Prequalified and From EUGMP Approved Plant

Dossiers Available: Ready CTD

Bioequivalence (BE/BA) study: Not Required for Injection

Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.